Be the first to like.

Share

And we thought the likes of Martin Shkreli with the 5,000% price hike of Daraprim, and then Heather Bresch of Mylan with the EpiPen fiasco of over $600 for a twin-pack for a drug that cost pennies, were a thing of the past after shaming and the congressional spotlight were bestowed upon these two CEOs.

But here we are again—now with Kaleo’s novel handheld talking auto-injector Evzio, designed to reverse opioid overdoses, increasing in price from $690 in 2014 to $4,500 in 2017, according to a recent report by Kaiser Health News.

 … Read More
Image: By James Heilman, MD – Own work, CC BY-SA 4.0, https://commons.wikimedia.org/w/index.php?curid=52872570

Be the first to like.

Share
Forbes #Medicine Robert Glatter, MD

Tags: , , , , , , , , , , ,

Leave a Reply